After an exhaustive 19-month research project, massively parallel sequencing is proven to generate robust, reliable, reproducible results.
Toxicology safety testing teams are under more pressure than ever. Here are three significant innovations helping tox teams achieve more success.
To meet the need for new vaccines for chemical & biological weapons, federal agencies & private companies must work together to overcome barriers.
Massively Parallel Sequencing has been the talk of DNA scientists, but now it’s closer than ever to becoming a valid asset for law enforcement.
Cyber Scientist Chris Domas heads to Black Hat to share his findings from a deep dive into x86 processors using a new tool called Sandsifter.
There is an urgent need for new medical countermeasures for CBRN threats. Why isn’t the industry providing them?
A vulnerability in software is a problem. A vulnerability in hardware is a disaster. They’re nearly impossible to fix and incredibly costly.
Inside Battelle gives you an all-access pass to the incredible work of Battelle researchers.
